Related references
Note: Only part of the references are listed.Cardiovascular Disease Associated With Androgen-Deprivation Therapy: Time to Give It Due Respect
Shehzad Basaria
JOURNAL OF CLINICAL ONCOLOGY (2015)
Risk and Timing of Cardiovascular Disease After Androgen-Deprivation Therapy in Men With Prostate Cancer
Sean O'Farrell et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
HEXIM1 plays a critical role in the inhibition of the androgen receptor by anti-androgens
I-Ju Yeh et al.
BIOCHEMICAL JOURNAL (2014)
Patterns of androgen deprivation therapies among men diagnosed with localised prostate cancer: A population-based study
Magdalena Lycken et al.
EUROPEAN JOURNAL OF CANCER (2014)
Androgen-deprivation Therapy and Cardiovascular Harm: Let's Not Throw Out the Baby with the Bathwater
Paul L. Nguyen
EUROPEAN UROLOGY (2014)
Complex Metabolic and Skeletal Changes in Men Taking Long-Term Androgen Deprivation Therapy
Stanislav Ziaran et al.
CLINICAL GENITOURINARY CANCER (2013)
Thromboembolic Events Following Surgery for Prostate Cancer
Mieke Van Hemelrijck et al.
EUROPEAN UROLOGY (2013)
Does Comorbidity Influence the Risk of Myocardial Infarction or Diabetes During Androgen-Deprivation Therapy for Prostate Cancer?
Nancy L. Keating et al.
EUROPEAN UROLOGY (2013)
Cohort Profile: The National Prostate Cancer Register of Sweden and Prostate Cancer data Base Sweden 2.0
Mieke Van Hemelrijck et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2013)
Analysis of the Lipid Profile and Atherogenic Risk during Androgen Deprivation Therapy in Prostate Cancer Patients
C. Salvador et al.
UROLOGIA INTERNATIONALIS (2013)
Patients with prostate cancer treated by ADT have significantly higher fibrinogenemia than healthy control
Stanislav Ziaran et al.
WORLD JOURNAL OF UROLOGY (2013)
Androgen deprivation and thromboembolic events in men with prostate cancer
Behfar Ehdaie et al.
CANCER (2012)
Prospective Study of Changes in the Metabolomic Profiles of Men during Their First Three Months of Androgen Deprivation Therapy for Prostate Cancer
Philip J. Saylor et al.
CLINICAL CANCER RESEARCH (2012)
Androgen-Deprivation Therapy for Nonmetastatic Prostate Cancer Is Associated With an Increased Risk of Peripheral Arterial Disease and Venous Thromboembolism
Jim C. Hu et al.
EUROPEAN UROLOGY (2012)
Endocrine prevention and treatment of prostate cancer
Teuvo L. J. Tammela
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2012)
Venous Thromboembolism in the Patient With Cancer Focus on Burden of Disease and Benefits of Thromboprophylaxis
Gary H. Lyman
CANCER (2011)
Pelvic Lymph Node Dissection is Associated With Symptomatic Venous Thromboembolism Risk During Laparoscopic Radical Prostatectomy
J. B. Eifler et al.
JOURNAL OF UROLOGY (2011)
Antiandrogen monotherapy in patients with localized or locally advanced prostate cancer: final results from the bicalutamide Early Prostate Cancer programme at a median follow-up of 9.7 years
Peter Iversen et al.
BJU INTERNATIONAL (2010)
Risk of thromboembolic diseases in men with prostate cancer: results from the population-based PCBaSe Sweden
Mieke Van Hemelrijck et al.
LANCET ONCOLOGY (2010)
Incidence, risk profile and morphological pattern of venous thromboembolism after prostate cancer surgery
J. Beyer et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Multi-institutional study of symptomatic deep venous thrombosis and pulmonary embolism in prostate cancer patients undergoing laparoscopic or robot-assisted laparoscopic radical prostatectomy
Fernando P. Secin et al.
EUROPEAN UROLOGY (2008)
EAU guidelines on prostate cancer
Axel Heidenreich et al.
EUROPEAN UROLOGY (2008)
The new Swedish Prescribed Drug Register -: Opportunities for pharmacoepidemiological research and experience from the first six months
Bjorn Wettermark et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Prothrombotic effects of prostasomes isolated from prostatic cancer cell lines and seminal plasma
Adil A. Babiker et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2007)
Venous thrombosis and changes of hemostatic variables during cross-sex hormone treatment in transsexual people
AWFT Toorians et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Reduced plasma levels of coagulation factors in relation to prostate cancer
WD Beecken et al.
PROSTATE (2002)
Risk factors for deep vein thrombosis and pulmonary embolism -: A population-based case-control study
JA Heit et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
Share Paper
